ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Astellas Announces Approval in Japan for the treatment of prostate cancer, Gonax for partial changes firstwordpharma
January 09, 2019Gonax??is a GnRH receptor antagonist with a subcutaneously injectable formulation. Astellas acquired exclusive development and commercialization rights of Gonax??for the use of prostate cancer treatment in Japan from Ferring Pharmaceuticals in January 200 -
Astellas Announces Approval in Japan for the treatment of prostate cancer, Gonax for partial changes firstwordpharma
January 09, 2019Gonax??is a GnRH receptor antagonist with a subcutaneously injectable formulation. Astellas acquired exclusive development and commercialization rights of Gonax??for the use of prostate cancer treatment in Japan from Ferring Pharmaceuticals in January 200
Pharma Sources Insight January 2025
